AI-powered platform that analyzes electronic health records to identify ideal candidates for clinical trials, reducing recruitment time by 40% while improving patient diversity for pharmaceutical researchers and CROs.
MediMatch AI addresses the $46B clinical trial bottleneck by using artificial intelligence to match anonymized patient records with trial criteria. This secure platform cuts recruitment timelines by 40% while improving participant diversity, offering pharmaceutical companies and research organizations unprecedented efficiency in trial setup and execution.
Core functionality
AI-driven analysis of anonymized Electronic Medical Records using NLP to interpret trial protocols and predictive matching algorithms. The HIPAA-compliant platform features:
- Automated patient identification across hospital systems
- Researcher dashboard for recruitment metrics tracking
- Secure data handling with FHIR-compliant APIs
- Predictive retention analytics
- Customizable outreach system for eligible patients
Target user and segment
Serving pharmaceutical research teams (mid-large), clinical research organizations (CROs), and academic medical centers conducting Phase II-IV trials in:
- Oncology studies
- Rare disease research
- Chronic condition trials
Primary markets: North America and European Union medical institutions.
Recommended tech stack
- AI Core: Python with PyTorch/TensorFlow
- Frontend: React.js dashboard
- Backend: Node.js with FHIR-compliant APIs
- Database: PostgreSQL + pgvector extension
- Infrastructure: AWS HIPAA-compliant (ECS/RDS)
- Orchestration: Apache Airflow pipelines + Terraform IaC
Estimated MVP hours and costs
Total development cost at €100/hour:
- EMR integration framework: 400h (€40,000)
- Core matching algorithm: 300h (€30,000)
- Researcher dashboard: 200h (€20,000)
- Security/compliance: 150h (€15,000)
- API infrastructure: 150h (€15,000)
- Total MVP cost: €120,000
SWOT-analysis
- Strengths: 40% faster recruitment vs manual screening, cross-institution data aggregation, retention prediction
- Weaknesses: Hospital EMR integration complexity, regulatory hurdles, high CAC
- Opportunities: $46B global trials market (5.8% CAGR), Asia-Pacific expansion, national health system partnerships
- Threats: Emerging competitors (Deep 6 AI), privacy regulation changes, hospital data-sharing resistance
First 1000 customers strategy
- LinkedIn Ads: Targeted clinical research directors (€50 CPA, 3% conversion)
- Conference Sponsorship: 15 therapeutic area events (€80k budget, 250 leads)
- Freemium Model: 3 free trial matches/study (projected 7% upgrade rate)
- CRO Partnerships: Revenue-sharing with top 20 CROs
- Total Acquisition Budget: €200k for 1,000 paid seats @ €1,200 ARPU
Monetization
Tiered SaaS Pricing:
- Basic: €1,500/month (5 trials, 10k patient scans)
- Pro: €4,000/month (20 trials, 50k scans + analytics)
- Enterprise: Custom (unlimited trials, EHR integrations)
Break-even: 85 Pro-tier customers cover €400k annual ops. Year 2 projection: 180 customers (€864k ARR)
Core Team: CTO, 2 developers, ML engineer, compliance officer, sales lead (€420k annual burn)
Market positioning and competitors
Regional Markets: North America (€18B), Europe (€12B), Asia (€9B)
Competitive Landscape:
- Deep 6 AI (Series B funded)
- TrialScope (document-focused)
- Medidata Solutions (legacy player)
Differentiation: Real-time cross-hospital matching with retention prediction
Sales Strategy: Inside sales for SMBs, field sales for hospitals, API partnerships
Micro-niches: Rare disease trials (€650k/study recruitment budget), pediatric oncology studies
